Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
https://www.newsnationnow.com/us-news/northeast/iran-adovacy-groups-rallies-nyc/...
CANYON, TX - Local seven-year-old Brayden Rogers got totally exposed this afternoon as he suffered an embarrassing hoops beatdown against his father....
How Administrative Power Replaces Accountability in Today’s Military...
